
Covation Biomaterials (CovationBio), a biomaterials company, has announced the appointment of Steven Ackerman as its new CEO. He succeeds Dean Trivits, who served as CEO following Michael Saltzberg’s retirement in 2023.
“It’s an honor to step into this role and lead CovationBio into a new era of sustainable innovation,” says Ackerman. “The growing global need for sustainable material innovation is clear. We’ll continue to build on our strong foundation to deliver even greater value to our partners and the planet.”
Ackerman succeeds Dean Trivits, who served as CEO following Michael Saltzberg’s retirement in 2023.
Since joining DuPont Biomaterials in 2010 and continuing through the creation of Covation Biomaterials in 2022, Ackerman has led global growth, technical advancement and innovation for the Sorona® business. Most recently, he was the vice president of product and technology. Under his direction, teams at three of the company’s laboratories worked on improving manufacturing processes, supporting operations and enhancing quality.
Ackerman has a Bachelor of Science in chemistry from Lehigh University in Bethlehem, Penn., and a master’s degree in materials science and engineering from the University of Delaware.